APA (7th ed.) Citation

M, G., M, S., H, L., Y, Z., PP, S., M, F., . . . SE, S. (2026). CXCR4-targeted PET/CT in early systemic sclerosis-associated interstitial lung disease: A prospective proof-of-concept study of in vivo inflammatory activity. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-08000-3

Chicago Style (17th ed.) Citation

M, Gernert, et al. "CXCR4-targeted PET/CT in Early Systemic Sclerosis-associated Interstitial Lung Disease: A Prospective Proof-of-concept Study of in Vivo Inflammatory Activity." European Journal of Nuclear Medicine and Molecular Imaging 2026. https://doi.org/10.1007/s00259-026-08000-3.

MLA (9th ed.) Citation

M, Gernert, et al. "CXCR4-targeted PET/CT in Early Systemic Sclerosis-associated Interstitial Lung Disease: A Prospective Proof-of-concept Study of in Vivo Inflammatory Activity." European Journal of Nuclear Medicine and Molecular Imaging, 2026, https://doi.org/10.1007/s00259-026-08000-3.